线,MRPL12 K163ccRCC

Xingzhao Ji1,2,3, Fuyuan Xue1, Ying Wang2

  • 1Shandong Provincial Key Medical and Health Laboratory of cell metabolism, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, China.

Cell death & disease
|August 26, 2025
PubMed
概括

在K163的MRPL12乙化抑制了清细胞癌 (ccRCC) 的进展. 恢复这种修饰增强了线粒体生物合成并抑制了瘤生长,这表明了ccRCC的新型治疗点.